decreased bone mineral content_Lrp5<tm1Grw>/Lrp5<tm1Grw>

http://metadb.riken.jp/0010124I129S1Sv129X1SvJLrp5tm1GrwLrp5tm1GrwLrp5tm1Grw

decreased bone mineral content_Lrp5<tm1Grw>/Lrp5<tm1Grw>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• low density lipoprotein receptor-related protein 5
  http://metadb.riken.jp/db/mgi_rdf/MGI:1278315

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Lrp5<tm1Grw>/Lrp5<tm1Grw>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Lrp5<tm1Grw>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased bone mineral content
  http://purl.obolibrary.org/obo/MP_0010124

文献

http://purl.org/net/cito/citesAsAuthority

• Rajendra. Kedlaya, et.al., Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome., Science translational medicine, 2013, 5
  http://rdf.ncbi.nlm.nih.gov/pubmed/24225945